PuSH - Publikationsserver des Helmholtz Zentrums München

Justenhoven, C.* ; Pierl, C.B.* ; Haas, S.* ; Fischer, H.P.* ; Baisch, C.* ; Hamann, U.* ; Harth, V.* ; Pesch, B.* ; Brüning, T* ; Vollmert, C. ; Illig, T. ; Dippon, J.* ; Ko, Y.D.* ; Brauch, H.*

The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.

Breast Cancer Res. Treat. 111, 171-177 (2008)
DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Cytochrome P450 1B1 (CYP1B1) is a major enzyme in the initial catabolic step of estradiol (E2) metabolism and belongs to the multitude of genes regulated by the estrogen receptor alpha (ERalpha). The common non-synonymous polymorphisms CYP1B1_1358_A>G and CYP1B1_1294_C>G increase CYP1B1 enzymatic activity. Given a relationship between CYP1B1 and breast tumor E2 level as well as E2 level and breast tumor ERalpha expression it is of interest to know whether CYP1B1 polymorphisms have an impact on the ERalpha status of breast cancer. We genotyped the GENICA population-based breast cancer case-control collection (1,021 cases, 1,015 controls) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and investigated in cases the association between genotypes and tumor ERalpha status (739 ERalpha positive cases; 212 ERalpha negative cases) by logistic regression. We observed a significant association between the homozygous variant CYP1B1_1358_GG genotype and negative ERalpha status (P = 0.005; OR 2.82, 95% CI: 1.37-5.82) with a highly significant Ptrend for CYP1B1_1358_A>G and negative ERalpha status (P = 0.003). We also observed an association of CYP1B1_1358_GG and negative PR status (P = 0.015; OR 2.36, 95% CI: 1.18-4.70) and a Ptrend of 0.111 for CYP1B1_1358_A>G and negative progesterone receptor (PR) status. We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter CYP1B1; Polymorphism; Breast cancer; ERalpha status
ISSN (print) / ISBN 0167-6806
e-ISSN 1573-7217
Zeitschrift Breast Cancer Research and Treatment
Quellenangaben Band: 111, Heft: 1, Seiten: 171-177 Artikelnummer: , Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)